GURMOHAN SYALI MD NPI 1932195138

NPI Information

  • NPI: 1932195138
  • Provider Name: GURMOHAN SYALI, MD
  • Classification: Internal Medicine - 207RX0202X
  • Specialization: Medical Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 235 N BELLE MEAD RD
    E SETAUKET, NY
    ZIP 11733
  • Phone: (631) 751-3000

Map and Directions

Get Directions

NPI Details

Gurmohan Syali, MD is a medical oncology internal medicine in E Setauket, NY with 25 years of experience. The provider is an internist who specializes in the diagnosis and treatment of all types of cancer and other benign and malignant tumors. This specialist decides on and administers therapy for these malignancies as well as consults with surgeons and radiotherapists on other treatments for cancer. Gurmohan Syali, MD NPI is 1932195138. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

235 N BELLE MEAD RD
E SETAUKET, NY
ZIP 11733-456
Phone: (631) 751-3000
Fax: (631) 751-3366

The NPI 1932195138 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
  • Injection, filgrastim (g-csf), excludes biosimilars, 1 microgram (HCPCS:J1442)
  • Injection, iron sucrose, 1 mg (HCPCS:J1756)
  • Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
  • Injection, pembrolizumab, 1 mg (HCPCS:J9271)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, paclitaxel, 1 mg (HCPCS:J9267)
  • Flow cytometry technique for dna or cell analysis, each additional marker (HCPCS:88185)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Magnesium level (HCPCS:83735)
  • Lactate dehydrogenase (enzyme) level (HCPCS:83615)
  • Gammaglobulin (immune system protein) measurement (HCPCS:82784)
  • Phosphate level (HCPCS:84100)
  • Uric acid level, blood (HCPCS:84550)
  • Ferritin (blood protein) level (HCPCS:82728)
  • Iron level (HCPCS:83540)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99490)
  • Iron binding capacity (HCPCS:83550)
  • Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
  • Folic acid level, serum (HCPCS:82746)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Vitamin d-3 level (HCPCS:82306)
  • Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
  • Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
  • Protein measurement, serum (HCPCS:84165)
  • Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
  • Injection, magnesium sulfate, per 500 mg (HCPCS:J3475)
  • Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
  • Injection, carboplatin, 50 mg (HCPCS:J9045)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
  • Red blood count, manual test (HCPCS:85044)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • Flow cytometry technique for dna or cell analysis, first marker (HCPCS:88184)
  • Detection test by nucleic acid for organism, amplified probe technique (HCPCS:87798)
  • Psa (prostate specific antigen) measurement, total (HCPCS:84153)
  • Injection of drug or substance into vein (HCPCS:96374)
  • Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
  • Blood test, clotting time (HCPCS:85610)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • Infusion, normal saline solution, 250 cc (HCPCS:J7050)
  • Thyroxine (thyroid chemical), free (HCPCS:84439)
  • Immunologic analysis for detection of tumor antigen, quantitative; ca 125 (HCPCS:86304)
  • Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
  • Testosterone (hormone) level, total (HCPCS:84403)
  • Red blood cell sedimentation rate, to detect inflammation, non-automated (HCPCS:85651)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Injection, fosnetupitant 235 mg and palonosetron 0.25 mg (HCPCS:J1454)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
  • Urinalysis, manual test (HCPCS:81002)
  • Beta-2 microglobulin (protein) level (HCPCS:82232)
  • Hemoglobin a1c level (HCPCS:83036)
  • Haptoglobin (serum protein) level (HCPCS:83010)
  • Administration of influenza virus vaccine (HCPCS:G0008)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
  • Drawing of blood for a medical problem (HCPCS:99195)
  • Acute hepatitis panel (HCPCS:80074)
  • Bilirubin level, total (HCPCS:82247)
  • Detection test by nucleic acid for multiple organisms, amplified probe(s) technique (HCPCS:87801)
  • Ige (immune system protein) level (HCPCS:82785)
  • Thyroxine (thyroid chemical), total (HCPCS:84436)
  • Transitional care management services for problem of high complexity (HCPCS:99496)
  • Blood test, basic group of blood chemicals (calcium, ionized) (HCPCS:80047)
  • Influenza vaccine split virus, preservative free (HCPCS:90662)
  • Detection test for candida species (yeast), amplified probe technique (HCPCS:87481)
  • Immunologic analysis for detection of tumor antigen, quantitative; ca 19-9 (HCPCS:86301)
  • Red blood cell concentration measurement (HCPCS:85014)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
  • Measurement c-reactive protein for detection of infection or inflammation, high sensitivity (HCPCS:86141)
  • Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen (HCPCS:87635)
  • Alpha-fetoprotein (afp) level, serum (HCPCS:82105)
  • Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99426)
  • Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
  • Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) (HCPCS:G0506)
  • Irrigation of implanted venous access drug delivery device (HCPCS:96523)
  • Transitional care management services for problem of moderate complexity (HCPCS:99495)
  • Parathormone (parathyroid hormone) level (HCPCS:83970)
  • Cortisol (hormone) measurement, total (HCPCS:82533)
  • Rheumatoid factor level (HCPCS:86431)
  • Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique (HCPCS:87651)
  • Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free (HCPCS:90674)
  • Blood smear for iron (HCPCS:85536)
  • Biopsy and aspiration of bone marrow sample for diagnosis (HCPCS:38222)
  • Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
  • Gene analysis (calreticulin), common variants (HCPCS:81219)
  • Gene analysis (janus kinase 2) variant (HCPCS:81270)
  • Gene analysis (janus kinase 2) targeted sequence analysis (HCPCS:81279)
  • Gene analysis (mpl proto-oncogene, thrombopoietin receptor) for detection of common variants (HCPCS:81338)
  • Molecular pathology procedure; physician interpretation and report (HCPCS:G0452)
  • Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique (HCPCS:87500)
  • Detection test by nucleic acid for multiple types influenza virus (HCPCS:87502)
  • Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique (HCPCS:87653)
  • Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique (HCPCS:87640)
  • Detection test by immunoassay technique for hiv-1 antigen and hiv-1 and hiv-2 antibodies (HCPCS:87389)
  • Coagulation assessment blood test, plasma or whole blood (HCPCS:85730)

The enumeration date for this NPI number is 9/22/2005 and was last updated on 3/24/2014.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RX0202XInternal MedicineMedical Oncology233548NEW YORKYes

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
10578S1MEDICARE PIN
202642840MEDICAIDNEW YORK
3I22773MEDICARE UPIN

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.